News

Singleron Biotechnologies, a front-runner in single cell multi-omics analysis, and Macrogen Europe, a state-of-the-art sequencing provider of fast and reliable genome analysis services…
Read More...

Ocugen, Inc. announced that it has submitted an Investigational New Drug application (IND) with the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial of…
Read More...

Lantern Pharma Inc., a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("AI") and machine learning (“ML”) platform to transform the cost,…
Read More...

Keymed Biosciences Inc. and Lepu Biopharma Co., Ltd  jointly announce a global exclusive licence agreement with AstraZeneca for CMG901, a potential first-in-class Claudin 18.2 antibody…
Read More...

Xspray Pharma AB has signed an agreement with EVERSANA to support the U.S. launch and commercialization of the company's first innovative cancer therapy Dasynoc for the treatment of…
Read More...

Sage Therapeutics, Inc. announced the European Medicines Agency (EMA) granted Orphan Drug Designation to SAGE-718 for the treatment of Huntington’s disease (HD). SAGE-718 is in…
Read More...

Moderna, Inc. and Life Edit Therapeutics Inc., an ElevateBio company announced a strategic research and development collaboration to discover and develop in vivo mRNA gene editing…
Read More...

GenScript ProBio and RVAC Medicines Pte. Ltd. announced an agreement to establish a strategic partnership for the manufacturing of GMP-grade plasmid DNA (pDNA) for its mRNA COVID-19…
Read More...

AstraZeneca’s tablet formulation of Calquence (acalabrutinib) has been approved in the European Union (EU) for the treatment of adult patients with chronic lymphocytic leukaemia (CLL).…
Read More...

Eterna Therapeutics Inc., a preclinical-stage biotechnology company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new…
Read More...

Beckley Psytech Ltd, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric disorders by transforming psychedelics into safe, effective and licensed…
Read More...

Vaxcyte, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s infant Investigational New Drug (IND) application for VAX-24, its lead, 24-valent…
Read More...

Alnylam Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s supplemental New Drug Application (sNDA) for patisiran, an…
Read More...

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for its respiratory syncytial virus (RSV) vaccine…
Read More...

Regeneron Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for pozelimab as a…
Read More...

Karyopharm Therapeutics Inc. and the Menarini Group announced that the United Kingdom's (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) has granted full Marketing…
Read More...

Biohaven Ltd. announced that it received Fast Track designation from the U.S. Food and Drug Administration (FDA) for taldefgrobep alfa, a novel anti-myostatin adnectin, for the…
Read More...

Valneva SE, a specialty vaccine company, today announced that the U.S. Food and Drug Administration (FDA) has completed a filing review of its Biologics License Application for…
Read More...

Clover Biopharmaceuticals, Ltd. announced that it entered into an exclusive agreement with Adimmune Corporation for Clover to distribute AdimFlu-S (QIS) in mainland China, where it is…
Read More...

Global biotechnology leader CSL announced that the European Commission has granted conditional marketing authorization (CMA) for HEMGENIX (etranacogene dezaparvovec), the first and only…
Read More...